Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01499017 · ClinicalTrials.gov registry record · Phase 1
A Single Dose Study Of PF-06291874 In Healthy Adult Subjects
A Phase 1 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT01499017 is a Phase 1 study that was terminated before completion, run by Pfizer. The registered enrollment target is 9 participants.
The verdict
NCT01499017, a Phase 1 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The primary purpose of this study is to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of PF-06291874 in healthy volunteers.
Interventions
- DRUG PF-06291874 or placebo
- DRUG PF-06291874 or Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01499017
The ClinicalTrials.gov registry entry for NCT01499017 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PF-06291874 or placebo is the first listed.
NCT01499017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01499017 about?
NCT01499017 is a clinical study titled "A Single Dose Study Of PF-06291874 In Healthy Adult Subjects". The primary purpose of this study is to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of PF-06291874 in healthy volunteers.
What is the current status of trial NCT01499017?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2011-11. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01499017?
The interventions under investigation include: PF-06291874 or placebo (DRUG), PF-06291874 or Placebo (DRUG).
Who is sponsoring clinical trial NCT01499017?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.